MAPS would want to include the main points of the therapy in its investigator’s brochure. Soon after sending in the application, the FDA decides if the review would be in the public desire. If it deems the research worthy, you get your IND selection. I waited all night, and at https://psychedelicfarmmeds.com/product/lyt-mushroom-chocolate-bar/